DE69515402D1 - Oxazolochinolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel - Google Patents

Oxazolochinolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel

Info

Publication number
DE69515402D1
DE69515402D1 DE69515402T DE69515402T DE69515402D1 DE 69515402 D1 DE69515402 D1 DE 69515402D1 DE 69515402 T DE69515402 T DE 69515402T DE 69515402 T DE69515402 T DE 69515402T DE 69515402 D1 DE69515402 D1 DE 69515402D1
Authority
DE
Germany
Prior art keywords
medicines
preparation
oxazoloquinolinone
derivatives
oxazoloquinolinone derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69515402T
Other languages
English (en)
Other versions
DE69515402T2 (de
Inventor
Samir Jegham
Jean Jacques Koenig
Frederic Puech
Philippe Burnier
Lydia Zard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of DE69515402D1 publication Critical patent/DE69515402D1/de
Application granted granted Critical
Publication of DE69515402T2 publication Critical patent/DE69515402T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Quinoline Compounds (AREA)
DE69515402T 1994-09-05 1995-09-01 Oxazolochinolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Expired - Lifetime DE69515402T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9410600A FR2724171B1 (fr) 1994-09-05 1994-09-05 Derives de 3,3a,4,5-tetrahydro-1h-oxazolo(3,4-a)quinolein-1-one, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
DE69515402D1 true DE69515402D1 (de) 2000-04-13
DE69515402T2 DE69515402T2 (de) 2000-10-19

Family

ID=9466686

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69515402T Expired - Lifetime DE69515402T2 (de) 1994-09-05 1995-09-01 Oxazolochinolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel

Country Status (28)

Country Link
US (1) US5641785A (de)
EP (1) EP0699680B1 (de)
JP (1) JP4225585B2 (de)
KR (1) KR100392523B1 (de)
CN (1) CN1055472C (de)
AT (1) ATE190311T1 (de)
AU (1) AU687591B2 (de)
CA (1) CA2157427C (de)
CZ (1) CZ286128B6 (de)
DE (1) DE69515402T2 (de)
DK (1) DK0699680T3 (de)
ES (1) ES2145886T3 (de)
FI (1) FI110945B (de)
FR (1) FR2724171B1 (de)
GR (1) GR3033554T3 (de)
HK (1) HK1013652A1 (de)
HU (1) HU218587B (de)
IL (1) IL115276A (de)
NO (1) NO306617B1 (de)
NZ (1) NZ272920A (de)
PL (1) PL184412B1 (de)
PT (1) PT699680E (de)
RU (1) RU2141482C1 (de)
SI (1) SI0699680T1 (de)
SK (1) SK281867B6 (de)
TW (1) TW356467B (de)
UA (1) UA41916C2 (de)
ZA (1) ZA957414B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1078632A1 (de) * 1999-08-16 2001-02-28 Sanofi-Synthelabo Verwendung von Monoamin Oxydase Inhibitoren zu Herstellung eines Medikaments zur Behandlung der Fettleibigkeit
WO2005090309A1 (en) * 2004-03-12 2005-09-29 Wyeth 1,2-dihydroquinoline derivatives and method for using the same to treat hiv infection
JP5351056B2 (ja) * 2007-03-09 2013-11-27 サノフイ 置換されたジヒドロ及びテトラヒドロオキサゾロピリミジノン、その製造並びに使用
RU2366430C2 (ru) 2007-05-23 2009-09-10 Виктор Иванович Рощин Ингибиторы моноаминооксидазы, лекарственное средство и фармацевтическая композиция
AR078171A1 (es) 2009-09-15 2011-10-19 Sanofi Aventis Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas
CN105949120B (zh) * 2016-05-27 2018-07-24 广东工业大学 一种四齿螯合型单喹啉衍生物及其制备方法和作为神经退行性疾病的金属离子调节剂的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624861B1 (fr) * 1987-12-21 1990-06-01 Delalande Sa Carbamates tricycliques, leur procede de preparation et leur application en therapeutique
ES2013391A6 (es) * 1989-02-08 1990-05-01 Consejo Superior Investigacion Procedimiento para la preparacion de derivados acetilenicos y alenicos de 2-aminometil -5-metoxiindoles.
JPH04295470A (ja) * 1991-03-22 1992-10-20 Wakamoto Pharmaceut Co Ltd モノアミンオキシダーゼ−ｂ酵素阻害活性を有する１，２，４−オキサジアゾール誘導体及びその製造法

Also Published As

Publication number Publication date
CA2157427A1 (en) 1996-03-06
JP4225585B2 (ja) 2009-02-18
ES2145886T3 (es) 2000-07-16
SI0699680T1 (en) 2000-10-31
KR100392523B1 (ko) 2003-11-12
PL310273A1 (en) 1996-03-18
IL115276A (en) 1998-12-06
FR2724171B1 (fr) 1997-01-03
PL184412B1 (pl) 2002-10-31
UA41916C2 (uk) 2001-10-15
EP0699680B1 (de) 2000-03-08
DK0699680T3 (da) 2000-08-21
FI110945B (fi) 2003-04-30
CN1055472C (zh) 2000-08-16
CZ286128B6 (cs) 2000-01-12
FI954141A0 (fi) 1995-09-04
SK108995A3 (en) 1996-06-05
IL115276A0 (en) 1996-01-19
GR3033554T3 (en) 2000-09-29
FI954141A (fi) 1996-03-06
NZ272920A (en) 1998-03-25
TW356467B (en) 1999-04-21
FR2724171A1 (fr) 1996-03-08
NO953458L (no) 1996-03-06
JPH0899881A (ja) 1996-04-16
AU687591B2 (en) 1998-02-26
SK281867B6 (sk) 2001-08-06
EP0699680A1 (de) 1996-03-06
HU9502578D0 (en) 1995-11-28
HU218587B (hu) 2000-10-28
ZA957414B (en) 1996-04-15
NO306617B1 (no) 1999-11-29
CN1128763A (zh) 1996-08-14
HK1013652A1 (en) 1999-09-03
NO953458D0 (no) 1995-09-04
US5641785A (en) 1997-06-24
DE69515402T2 (de) 2000-10-19
HUT73435A (en) 1996-07-29
CZ226295A3 (en) 1996-03-13
PT699680E (pt) 2000-08-31
CA2157427C (en) 2010-06-01
ATE190311T1 (de) 2000-03-15
KR960010648A (ko) 1996-04-20
RU2141482C1 (ru) 1999-11-20
AU3041595A (en) 1996-03-21

Similar Documents

Publication Publication Date Title
DE69204041T2 (de) Thiazolidinverbindeungen, deren Herstellung und therapeutische Verwendung.
ATE160148T1 (de) Sonnenfilter, diese enthaltende kosmetische lichtschutzzusammensetzungen sowie deren verwendung
DE3850861D1 (de) Imidazochinoxalinverbindungen und ihre Herstellung und Verwendung.
ATE130851T1 (de) Substituierte n-phenylpiperidine und arzneimittel daraus.
DE69515402T2 (de) Oxazolochinolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel
ATE124686T1 (de) Phenylalkylamine und diese enthaltende fungizide.
ATE86101T1 (de) Verwendung modifizierter diorganopolysiloxane als antioxydantien in der kosmetik und dermatologie.
DE69606337D1 (de) Trizyklische Derivate, ihre Herstellung, ihre Verwendung zur Herstellung von optisch aktivem oder racemischem Colchizin, Thiocolchizin, dessen Analoge oder Derivate, und Intermediate
FR2716198B1 (fr) Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.
FI20021652A (fi) Tratsodonin alkyylijohdannaisten valmistuksessa käyttökelpoisia välituotteita
RS50791B (sr) Farmaceutske kombinacije zasnovane na derivatima piridoindolona
ATE151090T1 (de) Herstellung von aktivierten carbamaten von polyalkylenglycol und ihre verwendung
NO994107D0 (no) Preparater for behandling eller forhindring av prostatakreft
FI912269A (fi) 3'-deamino - 4'deoxi - 4'-amino- 8 -fluorantracykliner och framstaellningsfoerfaranden foer dessa.
DE50001075D1 (de) 4-Alkanoyl-3-thiazoline und deren Verwendung als Riech- und Aromastoffe
ATE127806T1 (de) Antibiotikverbindungen und ihre herstellung.
DE59003446D1 (de) 13-Brom und 13, 14-Dibrom-Ergoline, ihre Herstellung und Verwendung in Arzneimitteln.
DE3865521D1 (de) 4-methyl-4-phenyl-1-pentanale, deren herstellung und verwendung als riechstoffe.
ATE246165T1 (de) 2-,5-,6-,7-,8-substituierte oct-2-en-4-one
ATE108449T1 (de) Hydrochinondiether, ihre herstellung und ihre verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-AVENTIS, PARIS, FR

R082 Change of representative

Ref document number: 699680

Country of ref document: EP

Representative=s name: TER MEER STEINMEISTER & PARTNER GBR PATENTANWA, DE